Prostatype Genomics AB Logo

Prostatype Genomics AB

Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.

PROGEN | ST

Overview

Corporate Details

ISIN(s):
SE0022574554 (+2 more)
LEI:
549300JO6MPCGPVHVU91
Country:
Sweden
Address:
Gustav III:s Boulevard 34, 169 73 Solna
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test, Prostatype®. The test is designed to provide a comprehensive assessment of the aggressiveness of diagnosed prostate cancer, particularly for patients with localized disease. It serves as a decision-making tool for clinicians and patients to help determine appropriate treatment strategies. The Prostatype® system uses existing biopsy tissue to analyze the expression of three key genes. This genetic data is combined with standard clinical parameters (PSA, Gleason Score, Tumor Stage) to calculate a proprietary P-score, which quantifies the risk of cancer mortality. By offering a more precise prognosis, the test aims to minimize both over- and under-treatment, thereby improving patient quality of life and saving healthcare resources.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Prostatype Genomics AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prostatype Genomics AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BrainCool AB Logo
Develops medical cooling systems to protect the brain after cardiac arrest, stroke, or injury.
Sweden BRAIN
Carl Zeiss Meditec AG Logo
Develops medical tech for ophthalmology & microsurgery, from diagnostics to surgical systems.
Germany AFX
CARMAT Logo
Develops an implantable artificial heart as a bridge-to-transplant for heart failure patients.
France ALCAR
CellaVision Logo
Provides digital microscopy solutions to automate blood analysis for global hematology labs.
Sweden CEVI
Develops bone grafts, artificial joints, and enzymes for the biopharmaceutical sector.
South Korea 049180
CG MedTech Co.,Ltd. Logo
Develops & sells orthopedic implants & devices using advanced biomaterial technology.
South Korea 056090
C.I.MEDICAL CO.,LTD. Logo
Mail-order supplier of 60k+ dental/medical items, also developing proprietary care products.
Japan 3540
Colan Totte.Co.,Ltd. Logo
Medical-grade magnetic wearables improving circulation & relieving stiffness for athletes & consumers.
Japan 7792
Coloplast Logo
Develops medical devices and services for people with intimate healthcare needs.
Denmark COLO
COLTENE Holding AG Logo
Develops and sells dental consumables and small equipment for dental professionals worldwide.
Switzerland CLTN

Talk to a Data Expert

Have a question? We'll get back to you promptly.